Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions

30.08.2010 - Lonza enters the viral based-manufacturing market today with its purchase of Vivante GMP Solutions. The acquisition advances Lonza's strategy to broaden its biologics custom...